glp-1 and vision loss GLP 1 Blindness Risk Ozempic and vision loss: GLP-1
Description
In addition to profoundly compromising quality of life and daily functioning, this disorder contributes to the pathogenesis of numerous chronic diseasesincluding hypertension, coronary artery disease, stroke, diabetes, and cognitive impairmentand has been correlated with elevated all-cause mortality risk (46)

For example: Week 1, right abdomen

Dose escalation, which is standard practice with most GLP-1 medications, helps to optimise therapeutic effects whilst minimising gastrointestinal side effects

Over the past five years, Ive watchedand written aboutthe massive rise in popularity of these medications with a professionally detached mix of curiosity and concern

Systematic Reviews [Internet]

Similarly, GLP-1 receptor agonist use was associated with an increased risk of suicidality compared with SGLT-2 inhibitors in crude analyses (crude incidence rates 4.3 v 2.7 per 1000 person years
